Rubin Jonathan
SEC CIK 1836067 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | SVP, Chief Medical Off | 14.3K | — | $36.3K | 22 | 2023-02-16 | 2026-08-12 |
Most active insiders at SUPN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Khattar Jack A. | Pres, CEO, Dir | — | $7.72M |
| 2 | Bhatt Padmanabh P. | CSO, SVP of IP | — | $5.42M |
| 3 | NEWHALL CHARLES W III | Dir | — | $1.27M |
| 4 | Mottola Frank | SVP, Chief Tech. Ops. Off | — | $1.10M |
| 5 | GEMAYEL GEORGES | Dir | — | $1.00M |
| 6 | Horich William Todd | SVP, Commercial Ops | — | $483.8K |
| 7 | Hudson Frederick M. | Dir | — | $271.7K |
| 8 | Sensenig Bethany | Dir | — | $228.3K |
| 9 | Rubin Jonathan | SVP, Chief Medical Off | — | — |
| 10 | Barlow Carrolee | Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-14 17:11 | 2026-08-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | M - OptEx | $0.00 | +750 | 14.3K | +6% | $0 |
| D | 2026-08-14 17:11 | 2026-08-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $46.57 | -363 | 14.0K | -3% | -$16.9K |
| D | 2026-02-26 | 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | A - Grant | $0.00 | +1,250 | 14.0K | +10% | $0 |
| D | 2026-02-26 | 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $50.69 | -675 | 13.3K | -5% | -$34.2K |
| DM | 2026-02-25 | 2026-02-24 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $30.27 | -1,643 | 12.2K | -12% | -$49.7K |
| DM | 2026-02-25 | 2026-02-24 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | A - Grant | $0.00 | +3,125 | 13.4K | +30% | $0 |
| D | 2025-09-26 | 2025-09-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | M - OptEx | $0.00 | +1,875 | 11.9K | +19% | $0 |
| D | 2025-09-26 | 2025-09-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $46.21 | -840 | 11.0K | -7% | -$38.8K |
| M | 2025-03-05 | 2025-03-05 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $33.05 | -1,468 | 9,635 | -13% | -$48.5K |
| D | 2025-02-24 | 2025-02-21 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | M - OptEx | $0.00 | +1,875 | 8,780 | +27% | $0 |
| D | 2025-02-24 | 2025-02-21 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | S - Sale+OE | $39.15 | -927 | 7,853 | -11% | -$36.3K |
| DM | 2025-02-24 | 2025-02-22+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | A - Grant | $0.00 | +3,250 | 8,603 | +61% | $0 |
| DM | 2024-12-30 | 2024-12-27 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | M - OptEx | $0.00 | +2,625 | 7,416 | +55% | $0 |
| DM | 2024-12-30 | 2024-12-27 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $35.59 | -1,102 | 6,595 | -14% | -$39.2K |
| D | 2024-02-27 | 2024-02-23 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $29.06 | -567 | 4,641 | -11% | -$16.5K |
| D | 2024-02-27 | 2024-02-23 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | A - Grant | $0.00 | +1,250 | 5,208 | +32% | $0 |
| D | 2024-02-26 | 2024-02-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | A - Grant | $0.00 | +750 | 4,261 | +21% | $0 |
| D | 2024-02-26 | 2024-02-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $27.94 | -303 | 3,958 | -7% | -$8,466 |
| D | 2023-12-26 | 2023-12-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | M - OptEx | $0.00 | +600 | 3,447 | +21% | $0 |
| D | 2023-12-26 | 2023-12-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $27.66 | -204 | 3,243 | -6% | -$5,643 |
| D | 2023-02-24 | 2023-02-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | A - Grant | $0.00 | +750 | 2,497 | +43% | $0 |
| D | 2023-02-21 | 2023-02-16 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Off | M - OptEx | $0.00 | +1,500 | 1,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations